CD8A and neoplasm: Produces IL-9 during TH9 differentiation involved in pro-inflammatory signaling and anti-tumor immunity. HIF1A also partners with mTOR to promote CD8 memory T cell generation. HIF1A also upregulates PD-L1 on tumor cells.